logo

PYXS

Pyxis Oncology·NASDAQ
--
--(--)
--
--(--)
2.84 / 10
Underperform

Technical assessment reveals 2.84/10 overall, depicting challenging technical structure. Constructive developments in no significant factors are mitigated by adverse signals in Long Lower Shadow, MACD Death Cross, Long Upper Shadow, MACD Golden Cross, and Marubozu White. Technical forecast: cautious.

FundamentalSentimentTechnical(2.84)

Analysis Checks(0/5)

Long Lower Shadow
Score2.13/10
Win Rate43.75%
Hist. Signals64
Avg Return0.13%
Long Upper Shadow
Score2.49/10
Win Rate47.14%
Hist. Signals70
Avg Return-0.17%
MACD Death Cross
Score1/10
Win Rate14.29%
Hist. Signals7
Avg Return-2.56%
MACD Golden Cross
Score4.8/10
Win Rate50.00%
Hist. Signals6
Avg Return5.99%
Marubozu White
Score3.79/10
Win Rate53.85%
Hist. Signals26
Avg Return0.16%
Technical Analysis of PYXS?
  • PYXS presents a Underperform setup with a Technical Score of 2.84/10. Key technical indicators highlight an RSI of 50.70 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 1.47. Traders should monitor key support at 1.43 and resistance at 1.53.